Humanize Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Humanize Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, g…

2016-03-11 Pimpri, Maharashtra Active Unlisted Active Compliant
Share
Connect MCP
HP Humanize Pharmaceuticals Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Humanize Pharmaceuticals Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
73/100
Trust Score
Moderate

Humanize Pharmaceuticals Private Limited is assessed as Moderate with a Trust Score of 73/100. Humanize Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2016, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 11 Aug 2026 from the latest processed filings. Humanize Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
73/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
25/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Working-capital cover adequate.

Charges position: 1 open (1.00 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
IJAJ ABDULGANI KHALIF 01234567 Director 01/04/2018 6 yrs Approved
PRITHVIRAJ BHUPAL DESAI 01234567 Director 01/04/2018 6 yrs Approved
VISHWANATH KADAPPA HANJI 01234567 Director 01/04/2018 6 yrs Approved
AJIT RAMRAO DESAI 01234567 Director 01/04/2018 6 yrs Approved
SWATI GAJENDRA BANDI 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • 3 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Key managerial personnel: VISHWANATH KADAPPA HANJI (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 60
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Operating for 10+ years.
Active GST registration(s).
Distress signals & risk flags
Negative net worth.
3 director exits within 2 years.
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence80/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment53/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 1.00 cr already registered.
  • Compliance record supports lending.
Investor view55/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
21 Mar 2025
Charge created
Others - 1.00 cr
24 Feb 2025
Director ceased
IJAJ ABDULGANI KHALIF
Director ceased
SWATI GAJENDRA BANDI
Director ceased
PRADEEP BALKRISHNA SANKPAL
12 Oct 2017
Director ceased
VIJAY NAIK VILAS
05 Sep 2016
Director ceased
RAVINDRA DUNDAPPA HATTARKI
Director ceased
VISHAL NARENDRA NIMBALKAR
11 Mar 2016
Incorporated
Registered with Roc Pune
Director appointed
IJAJ ABDULGANI KHALIF (Director)
Director appointed
PRITHVIRAJ BHUPAL DESAI (Director)
Director appointed
VISHWANATH KADAPPA HANJI (Managing Director)
Director appointed
AJIT RAMRAO DESAI (Director)
Director appointed
SWATI GAJENDRA BANDI (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2021 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Corewell Foams Private Limited U17100RJ2018PTC062221 Jaipur, Rajasthan, India
Happyfest Solutions Private Limited U74999KA2016PTC098868 Bangalore, Karnataka, India
Radha Stores Private Limited U51391WB1997PTC085929 Kolkata, West Bengal, India
Sabziwala U01400DL2016PTC291766 New Delhi, Delhi, India
Taqht International Private Limited U29269GJ2020PTC113209 Surat, Gujarat, India
Medicare Remedies Private Limited U74999MH2011PTC218798 Airoli, Maharashtra, India
Tbk Shri Ram Tile Bath Kitchen Private Limited U90009DL2009PTC188429 New Delhi, Delhi, India
Heritage Lights N More Private Limited U52100BR2014PTC022464 Patna, Bihar, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Humanize Pharmaceuticals Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Humanize Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 70/100, margin trends, ownership structure and peer set for Humanize Pharmaceuticals Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 73/100, distress signals and MSME payment-delay disclosures - know whether Humanize Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Humanize Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Humanize Pharmaceuticals Private Limited an active company?

Humanize Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Humanize Pharmaceuticals Private Limited financially healthy?

Humanize Pharmaceuticals Private Limited has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Humanize Pharmaceuticals Private Limited?

Its overall Trust Score is 73/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Humanize Pharmaceuticals Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Humanize Pharmaceuticals Private Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Humanize Pharmaceuticals Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Humanize Pharmaceuticals Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.